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The cDNA gene coding for the a subunit of Xenopus laevis casein kinase II was mutated using the overlap extension PCR method. The mutation 
substituted elutamic acids for Lys” and LYS~~, changing the charge distribution of a very basic sequence found in the a subunit. Expression of the 
mutated c6NA in a pT7-7 vector in E. coli yielded an active mut~t r~ombinant protein that was extensively purified. This mutant was not 
si~ificantly affected in its app. K,,, for casein or a model peptide substrate, nor in its interaction with the activatingfl subunit. Inhibition by quercetin 
and by 5,6-dichloro-I-J&r+ribofuranosyl benzimidazole was also the same for mutant and wild type subunits. However, the CKII IzE’~E~~ mutant 
was at least one order of magnitude less sensitive to inhibition by polyanionic inhibitors such as heparin, poly U, copolyglutamic acid:tyrosine (4:l) 
and 2,3 diphosphoglycerate. 
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1. In~~u~tion 
Casein kinase II (CKII) is an ubiquitous eukaryotic 
protein kinase that plays an important role in the phos- 
phorylation of many proteins that participate in nucleic 
acid synthesis and in cell proliferation [l-3]. The native 
CKII is a heterotetramer with an ad2 or cur’/& structure. 
The a and a’ subunits have an A&, of 38 to 44 kDa and 
possess the catalytic activity. The /3 subunits with A& 
between 25-27 kDa serve a regulatory function, increas- 
ing S- to IO-fold the activity of a. 
The cDNAs coding for the 01 and B subunits of CKII 
in a number of species have been cloned and sequenced 
[CC-S]. These studies have shown that both subunits have 
been highly conserved throughout evolution. 
Studies dealing with the structure and function of 
CKII are now being carried out by a number of labora- 
tories with the help of site directed mutagenesis and ex- 
pression of the recombinant mutated proteins in E. coli 
[9,10]. Our laboratory has recently reported the expres- 
sion of wild type and mutant subunits of the Xenopus 
laevis CKII [l 11. 
Hu and Rubin [5] designed a mutant of the a subunit 
of CKII of Cue~~r~~~ditis e~e~~~~ in which lysines 74 
and 75 were substituted by glutamic acid. These authors 
*Corresponding author. Fax: (56) {2) 737 6320. 
found that this mutation was catalytically active, show- 
ing a very small increase in the apparent k-;, for casein. 
However, they observed that substitution of these lysines 
for glutamic acids greatly reduced the capacity of hepa- 
rin to inhibit its catalytic activity. 
In this report we present the results obtained with a 
similar mutant prepared by substituting lutamic acid in 
the positions corresponding to lysines 75 and 76 in the 
cr subunit of CKII from X Zaevis (CKII aE75E76). These 
results confirm and extend the previous observation of 
these authors. The double mutation significantly reduces 
the inhibition caused by other polyanions such as the 
copolymer of glutamic acid and tyrosine (ratio 4:1), by 
poly U and by 2,3-diphosphoglycerate. However, this 
mutation does not significantly affect the activation of 
the a subunit caused by the p subunit or the inhibition 
caused by quercetin or by 5,6-dichloro- 1 +D-ribofura- 
nosy1 benzimidazole (DRB). 
2. Materials and methods 
2. I. Preparation of recombinant a and @ subunits of CW from 
X. laevis 
Cloning and sequencing of the cDNA coding for the tc anda subunits 
of CKII of X. Iaevis were described earlier [S]. The insertion of the a 
subunit cDNA into a pT7-7 expression vector and its expression and 
the purification of the resulting protein was described in detail by 
Hinrichs et al. [l 11. This same publication reports the expression of the 
/? subunit from a pGEX 2T vector, the purification of the fusion protein 
by glutatione-agarose b ads and the release of the B subunit by throm- 
bin treatment. The purified recombinant proteins prepared by this 
method are fully active and can reconstitute a functional holoenzyme. 
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2.2. Preparation of the CKII aE75E7b mutant 
The mutant CK aE7SE76 was prepared from the starting ~7-7 clone 
of the wild type a subunit by the method of ‘overlap extension’ using 
the polymerase chain reaction [12]. Two amplifications were made 
using the original clone as template. The first one used the primer 
5’-CCCCTGCCAGATGTCAGGACCTGTG-3’, which contains a 
Pd site and the initial 5 codons of CKII a and the primer 5’- 
AAGCCTGTGAAG(G)AG(G)AGAAAATTAAGC-3’ which con- 
tained the double mutant indicated by brackets where G’s replaced A’s. 
For the second amplification the primers used were 5’- 
GCTTAATTTTCT(C)CT(C)CTTCACAGGCTT-3’ which contained 
the complementary double mutant primer where the bracketed C’s have 
replaced the original T’, and S-CCCCTGCAGTCATACTGGCGCT- 
ACT-3’ containing a PstI sequence, the stop codon and the last car- 
boxy1 end triplets. 
The overlapping products of these amplifications were mixed and a 
third amplification run using the two terminal primers with PstI sites 
previously described. The resulting mutated full-length cDNA was pu- 
rified in a 1% agarose gel, treated with PstI and subcloned in the 
expression vector pT7-7 [13] and introduced into E. coli BL 21 (DE3) 
for preparation of the mutant protein. The full-length cDNA obtained 
after the mutation was completely sequenced to ascertain that no other 
sequence alterations had occurred during the process. Purification of 
the recombinant mutant protein was carried out as described for the 
wild type subunit [ll]. 
2.3. Assay of CKII activity 
Reactions (50 ~1) contained 50 mM HEPES, pH 7.8, 150 mM KCl, 
7 mM MgC12. 0.5 mM dithiothreitol, and 100 PM [y-“P]ATP (500& 
1000 cpmlpmol). Assays also contained recombinant subunits and 
5.0 mg/ml of desphosphocasein or the peptlde RRREEETEEE [14] as 
the protein substrate. The reaction was started by the addition of the 
enzyme and the incubation was for 10 min at 30°C. It has been deter- 
mined that under these conditions the reaction is linear for at least 
30 mm. An aliquot was spotted on a 2 x 1 cm Whatman P81 phophocel- 
lulose paper which was then immersed in 75 mM phosphoric acid. The 
paper was washed 3 times in the same acid, dried and counted. Values 
reported have been corrected for controls run in the presence of heat 
denatured enzyme. All assays were performed in duplicate and are 
representative of two to four experiments. 
2.4. Materials 
Oligonucleotides were purchased from the Centro de Sintesis y Se- 
cuenciacibn de Biomol&culas of the University of Chile. 
Copoly (Glu:Tyr) (4: 1) (M, 46,000), quercetin, DRB, human throm- 
bin, glutathione-agarose b ads, polyurldylic acid, 2,3-diphosphoglycer- 
ate were obtained from Sigma Chemical Co. 
3. Results 
The X. luevis CKII aE”E”j subunit expressed in E. coli 
is catalytically active. Its apparent X, for casein was 
calculated to be 4.5 mg/ml, in comparison with an appar- 
ent K, value of 2.5 mg/ml for the wild type subunit 
(CK a,). The app. K,,, for the model peptide RRREE- 
ETEEE was 0.23 mM for the CK a,,, while for CK 
LxE”E’~ the value was 0.54 mM (not shown). 
Fig. 1 shows the effect of adding increasing concentra- 
tions of /3 on the activity of the wild type and mutant a 
subunits. It is clear that there is no major difference in 
the concentration of p subunit required to interact with 
the wild type and mutant a subunits and that the degree 
of activation attained is also similar. 
As reported by Hu and Rubin [5], these mutations 
greatly reduce the capacity of heparin to inhibit its cata- 
lytic activity. In the case of X Zaevis enzyme, the I,, value 
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Fig. 1. The activation of the wild type and mutant a subunits by 
different concentrations of recombinant/3. Different amounts of recom- 
binant /3 subunit were added to the reaction mixture containing 48 ng 
of CKII a wild type (0) and to 50 ng of CKII aE75E76 (0) and the kinase 
activity with casein as substrate was assayed as detailed in section 2. 
The activity of CKII awT without B was 21.0 pmol of 32P incorporated 
into casein and for CKII aE75E76 without B it was 28.5 pmol. 
is increased from 0.30 ,&ml for the wild type to 4 pg/ml 
for the mutant (Fig. 2A). 
The effect of other inhibitors was also tested. Fig. 2B 
shows the effects of poly U and Fig. 3A of the copolymer 
glutamic acid:tyrosine (ratio 4:l) on the activity of the 
wild type and mutant a subunits. It is evident that the 
mutations also affect very significantly the capacity of 
these other polyanions to inhibit the enzyme. Reduction 
in the I,, values of Poly U from 8 yg/ml to 125 ,@ml and 
from 0.025 PM to 0.2 PM for copolyglu:tyr were ob- 
served. 
Inhibition by 2,3-diphosphoglycerate was also tested 
and again the mutant a subunit was an order of magni- 
tude less susceptible to inhibition by this compound (not 
shown). 
Fig. 3B shows the inhibition of the activity of the wild 
type and mutant a subunits by quercitin, a polycyclic 
flavone that is not polyanionic in nature. In this case, 
there is no difference in the inhibition of the two a sub- 
units. Similar results were obtained with the nucleotide 
analog 5,6 dichloro-1-a-o-ribofuranosyl benzimidazole 
(not shown). 
4. Discussion 
The generation of site-directed mutations in the re- 
combinant subunits of casein kinase II permits the study 
of some structure-function relationships in this enzyme. 
Comparison of the amino acid sequences that are not 
part of the conserved catalytic domains of different 
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Fig. 2. The effect of heparin and poly U on the activity of CKII awT and CKII OZE’~E’~, The activity of CKII czWT (0) and of CKII CZE’~E’~ (0) were 
measured in the presence of different concentrations of heparin (A) or polyuridylic acid (B). The activity assay was as described in section 2. In A, 
100% activity was 16.5 and 15.7 pm01 of3’P incorporated for aw7 and &E75E76, respectively. In B the 100% values were 8.8 and 7.7 of “P incorporated 
for the fractions in the same order. 
kinases has led to the postulation that the highly 
basic region of CKII (r: that stretches from amino acid 
71 to amino acid 78 may be involved in the interaction 
with the acidic regions that are present in CKII substrate 
proteins (1 or 2). Presumably this same region would 
also be responsible for interaction with polyanionic in- 
hibitors and with the acidic clusters present in the B 
subunit. 
The results presented confirm and extend those re- 
ported by Hu and Rubin [5] who had prepared a similar 
mutant of the a subunit of CKII of C’. elegans in which 
Lys74 and LYS’~ were substituted with glutamic acid. 
These authors only tested this mutant with regards to its 
app. Km for casein and for its I,, by the potent inhibitor, 
heparin. Our results agree with the fact that the mutant 
shows a small increase in the apparent K, for casein and 
for a model peptide substrate while there is a large reduc- 
tion in the inhibitor potency of heparin. It is clearly 
demonstrated, in addition, that the mutation affects the 
interaction of a with other polyanionic inhibitors such 
as poly U, copolyglu:tyr (4: 1) and 2,3 phosphoglycerate, 
while the activity of non polyanionic inhibitors is not 
affected by this mutation. 
The fact that the app. K,.,, for the casein is not signifi- 
cantly affected by the mutation is unexpected because it 
was thought that the same region of the enzyme was 
responsible for its interaction with the acidic sequences 
of the substrate as with the polianionic inhibitors. The 
results obtained would argue that the enzyme-substrate 
interaction is influenced by structural features that go 
beyond the ionic interactions of this charged region of 
the molecule. Similarly, the interaction with the /3 sub- 
unit is not affected significantly by the mutation indicat- 
ing that the interaction with the regulatory subunit also 
involves other aspects of its structure. Previous studies 
from this laboratory [15,16] have indicated that in addi- 
tion to their acidic character, the presence of aromatic 
structures uch as those found in copolyglu:tyr peptides, 
in nucleic acids and in polyglutamic derivatives of folic 
acid considerably influence their affinity for CKII. 
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Fig. 3. The effect of copolyglutamic acid:tyrosine (41) and of quercetin on the activity of TV W and CKII CLE”E’~. The activity of CKII a, (0) and 
CKII IzE”E’~ (0) was assayed in the presence of increasing concentrations of the random copolyglutamic acidztyrosine in a ratio of 4: 1 (A) and of 
quercetin (B). The 100% activities in (A) were 7.1 and 7.0 pmol, and in (B) 8.8 and 7.8 pmol of 32P incorporated into casein for a, and c&*E’~, 
respectively. 
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